Frank Striggow

Device and method for measuring impedance in organotypic tissues

Polymutant tau protein variants and their use for recapitulating human tauopathies

NOVEL MULTIFUNCTIONAL PEPTIDASE INHIBITORS, ESPECIALLY FOR MEDICAL USE

Drug preparation comprising α-lipoic acid, ambroxol and/or inhibitors of the angiotensin-converting enzyme (ACE) and its use for the treatment of neurodegenerative diseases

DEVICE AND METHOD FOR MEASURING IMPEDANCE IN ORGANOTYPIC TISSUES

Tissue-Based Assay System for Alzheimer-Specific Degeneration and Pathology

Model System for Testing the Efficacy of Pharmaceutical Preparation on Inflammatory Processes in the Nervous System

Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological inflammatory, neuronal and other diseases

Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases

Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases

Device and method for automatically carrying out laboratory procedure steps

Method of treating cerebral ischemia with hydrogenation products of frankincense extracts

Vital mammalian heart tissue cells maintained ex vivo, processes of the collection and cultivation thereof and their use

Use of inhibitors of enzymes having activities of amino peptidase N and/or dipeptidyl peptidase IV and of pharmaceutical preparations thereof for a therapy and prevention of chronical neurodegenerative diseases